Tissue Kallikrein as a Mediator in Stroke Outcomes among Patients With Metabolic Syndrome: A Multicenter Study Integrating Big Data and Biomarkers Metabolic syndrome is associated with adverse stroke outcomes. KLK1 acts as a mediating factor linking metabolic syndrome and stroke prognosis. KLK1 could be a therapeutic target for stroke patients ...

#Article in #MedComm
Tissue Kallikrein as a Mediator in Stroke Outcomes among Patients With Metabolic Syndrome: A Multicenter Study Integrating Big Data and Biomarkers doi.org/10.1002/mco2...

#BigData #bioinformatic #KLK1 #MachineLearning #MetabolicSyndrome #stroke